July 1, 2020 marked the start of another year of funding for the Colorado Cancer Screening Program (CCSP) for Patient Navigation but just like most things in 2020… it’s not just another year for a decade long program.
Winter in the United States can produce some of the most dangerous weather for the aviation industry, including freezing rain, freezing drizzle, and sleet. Those are the ideal conditions for a field campaign focused on collecting in-flight data in some of the most treacherous North American icing conditions.
Tiny, opossum-like animal lived alongside dinosaurs in Alaska's polar forests roughly 69 million years ago and faced months of winter darkness.
While overall rates of colorectal cancer are down, the rate of young people getting the disease is up 22 percent over two decades. International leaders meet in Colorado to set the research agenda to figure out why.
Even though climate change is expected to reduce the total amount of U.S. snowfall this century, it's unlikely to significantly rein in the most powerful nor'easters that pummel the East Coast, new research indicates.
University of Colorado Cancer Center study shows that doctors may be underestimating the risk of and thus under-treating stage I and II breast cancers diagnosed within 10 years of childbirth.
Cover crops grown in fields during winter may be warming temperatures in the northern United States and southern Canada, according to a new study by scientists at the National Center for Atmospheric Research. The crops, a land management strategy farmers use between growing seasons, create a darker surface than a snow-covered field, absorbing more heat from the Sun and producing a local warming effect.
Following a spinal cord injury, the body’s internal clocks fall out of sync, impacting temperature, hormones and immunity, according to new research funded by the U.S. Department of Defense. The findings could lead to “chronotherapies” to reset clocks and improve recovery.
A new brain imaging study shows that when we imagine something we fear, it stimulates similar neural pathways as when we experience it. The findings suggest imagination can be a powerful therapeutic tool for helping people get over phobias or post traumatic stress.
Lior Gross and Jewish Studies instructor Eyal Rivlin publicly launched their new gender-inclusive Hebrew language—the Nonbinary Hebrew Project—in late October.
CU Boulder researchers are playing an important role in a NASA mission to grab a piece of an asteroid and return it to Earth.
Carson Bruns is working to put body art to use, designing high-tech inks that may one day signal your temperature or changes in blood chemistry.
Five of the six top finishers in this month's New York City Marathon wore a cutting-edge shoe said to reduce the amount of energy required to run by 4 percent. A new study explains how the shoe works and answers some questions raised by critics.
CU Cancer Center study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Turning off protein metabolism kills these cells.
How ideas move through academia may depend on where those ideas come from as much as their quality, a recent study suggests.
Researchers at the University of Colorado Boulder have uncovered the statistical rules that govern how gigantic colonies of fire ants form bridges, ladders and floating rafts.
University of Colorado Boulder neuroscientist Linda Watkins has developed an opioid-free, long-lasting shot for management of chronic pain. So far, it has been tested in more than 40 dogs with impressive results and no adverse effects. Human trials are underway.
Navitoclax plus A-1210477 not only killed melanoma cells, but also killed the melanoma initiating cells (aka cancer stem cells) that often resist therapy.
University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."
A University of Colorado Cancer Center study published today in the journal Cancer Cell shows that leukemia undercuts the ability of normal cells to consume glucose, thus leaving more glucose available to feed its own growth.
CU Boulder researchers have identified a family of small molecules that turn off defense mechanisms inside bacteria that enable them to resist antibiotics. The compounds could ultimately be given alongside existing medications to rejuvenate them.
Results of ALTA-1 trial: Patients given brigatinib saw a statistically significant 51 percent reduction in the risk of progression or death compared with those given crizotinib.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
Omacetaxine (to block protein synthesis) with venetoclax (to block oxidative phosphorylation), was highly effective against CD123+ leukemia stem cells.
Rattlesnakes and other venomous reptiles may bite more people during rainy years than in seasons wracked by drought, a new study shows.
Increasing natural disasters and aging schools built before modern codes existed put thousands of school-aged children at risk each day. A new guide and webinar series offer solutions.
Best known as a pathogen that causes food poisoning or steals nutrients away from its host, the E. coli bacterium actually plays a critical role in promoting health by producing a compound that helps cells take up iron.
Doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.
A new, super-insulating gel developed by researchers at the University of Colorado Boulder could dramatically increase the energy efficiency of skyscrapers and other buildings, and might one day help scientists to build greenhouse-like habitats for colonists on Mars.
Adolescents with serious conduct and substance use problems are five times more likely to die prematurely than their peers, with roughly one in 20 dying by their 30s, according to new research.
University of Colorado Cancer Center study shows that common laboratory tests used to determine ROS1 status may return false-negative results, meaning that some patients who could benefit from ROS1-directed therapy may be slipping through the cracks.
Clinical trials at CU Cancer Center and elsewhere result in FDA approval of the drug ivosidenib for the treatment of adult patients with IDH1+ AML.
Showing results
1–50 of 336
RSS Feeds by Section